Vascular Invasion, Tumor Deposits More Prognostic Than TNM for Rectal Cancer Vascular Invasion, Tumor Deposits More Prognostic Than TNM for Rectal Cancer
In patients with rectal cancer, MRI assessment of non-nodal tumor nodules and extramural venous invasion are more accurate prognosticators than tumor size and lymph node metastases, researchers say.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 1, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

HPV Vaccination and Substantial Reduction in Cervical Cancer HPV Vaccination and Substantial Reduction in Cervical Cancer
A review from Sweden of more than 1 million girls/women vaccinated in 2006 – 2017 shows a substantial reduction in the risk for invasive cervical cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 1, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Innate Immune Response Produces'Phenomenal' Breast Cancer Control Innate Immune Response Produces'Phenomenal' Breast Cancer Control
A unique study illustrates the extraordinary power of the immune system to control cancer when it's able to recognize the tumor.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 1, 2020 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.
NEW BRUNSWICK, N.J., October 1, 2020 -- Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. (“Momenta”), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion.“We’re delighted to welcome Momenta’s talented team to the Janssen Pharmaceutical Companies of Johnson & Johnson and to begin our work together to further advance patient care in autoantibody-driven diseases,” said Jennifer Taubert, Executive Vice President, Worldwi...
Source: Johnson and Johnson - October 1, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

High TMB Predicts Response to Pembrolizumab High TMB Predicts Response to Pembrolizumab
Details of the data that led to FDA approval of tumor mutation burden (TMB) as a biomarker for pembrolizumab use in advanced cancers have now been published.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Physicians Misjudge a Terminal Patient's Life Span: Is It Fraud? Physicians Misjudge a Terminal Patient's Life Span: Is It Fraud?
Physicians can recommend that patients receive hospice care when they have less than 6 months to live; but what if their prognosis is not accurate? Are doctors at risk?Medscape Business of Medicine (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2020 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

Free online blood cancer conference from National Comprehensive Cancer Network (NCCN)
(National Comprehensive Cancer Network) The NCCN Virtual Nursing Forum and Annual Congress: Hematologic Malignancies (#NCCNhem20) will provide the latest evidence and expert consensus on emerging practices and debates in blood cancer treatment, online Thursday, October 8, 2020 - Saturday, October 10, 2020.NCCN 2021 Virtual Annual Conference is also scheduled to take place online Thursday, March 18, 2021 - Saturday, March 20, 2021. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 30, 2020 Category: Cancer & Oncology Source Type: news

Hold Off Radiotherapy After Prostate Cancer Surgery Hold Off Radiotherapy After Prostate Cancer Surgery
Instead of adjuvant radiotherapy after prostatectomy, observation and early salvage radiotherapy offer equal outcomes with fewer side effects.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 29, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

FDA OKs Mepolizumab (Nucala) for Hypereosinophilic Syndrome FDA OKs Mepolizumab (Nucala) for Hypereosinophilic Syndrome
Mepolizumab is indicated for adults and children aged 12 years and older with HES for 6 months or longer without an identifiable nonhematologic secondary cause.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 29, 2020 Category: Allergy & Immunology Tags: Hematology-Oncology News Alert Source Type: news

CRC Risk: Raised by Meat/Alcohol, Lowered by Aspirin/NSAIDs CRC Risk: Raised by Meat/Alcohol, Lowered by Aspirin/NSAIDs
A new meta-analysis has largely confirmed what is already known about lifestyle factors that increase or lower the risk for colorectal cancer (CRC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 29, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Disparities: One of the Most Pressing Public Health Issues Cancer Disparities: One of the Most Pressing Public Health Issues
"There is...a need for our nation's leaders to take on a much bigger role in confronting and combat-ing the structural and systemic racism that contributes to health disparities," says the AACR.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC Divergent Findings With Paclitaxel and Nab-Paclitaxel in TNBC
Certain patients with triple-negative breast cancer (TNBC) may benefit when atezolizumab is combined with nab-paclitaxel but not with paclitaxel, a pair of phase 3 trials suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted'Long-Running' Conspiracy: Cancer Center's Ex-Top Doc Indicted
The former head of Florida Cancer Specialists has been indicted by a federal grand jury for conspiring to restrict cancer patients'choice of a treatment provider.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Insulin Resistance and Racial Disparities in BC Prognosis Insulin Resistance and Racial Disparities in BC Prognosis
Is insulin resistance a contributing factor to the racial disparities in breast cancer prognosis? A new study examines the possibility.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Predicting Complications of Cytoreductive Nephrectomy in mRCC Predicting Complications of Cytoreductive Nephrectomy in mRCC
Patients with higher intraoperative blood loss and those treated at lower-volume surgical centers had a greater risk of high-grade complications after undergoing CN for mRCC, according data analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 26, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Hepatocellular Carcinoma Shows Risk Factor Shift Hepatocellular Carcinoma Shows Risk Factor Shift
The most common form of liver cancer has seen a demographic shift, with incidence highest in the Hispanic population. The good news in HCC is that rates appear to be declining among young men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 25, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Global Stomach Cancer Deaths Decline as CRC Deaths Stagnate, Rise Global Stomach Cancer Deaths Decline as CRC Deaths Stagnate, Rise
A global analysis of premature deaths from noncommunicable diseases has shown mixed results for gastrointestinal cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 25, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

US Health Department's Caputo Has Cancer, Spokesperson Says US Health Department's Caputo Has Cancer, Spokesperson Says
Michael Caputo, who is on leave from his role as spokesperson for the U.S. Department of Health and Human Services after accusing government scientists of sedition, has metastatic cancer, a state lawmaker said.Associated Press (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 25, 2020 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

What Do You Think of Virtual Medical Meetings? What Do You Think of Virtual Medical Meetings?
If you have participated in a virtual medical meeting this year, tell us about your experience.Medscape Reader Polls (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 25, 2020 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

For Immunotherapy in TNBC, Nab-paclitaxel Is a Must For Immunotherapy in TNBC, Nab-paclitaxel Is a Must
Why are results so different between IMpassion130 and IMpassion131? There is no clear answer, says Dr Kathy Miller.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor
When used in combination with abiraterone, the new drug showed activity in metastatic castration-resistant prostate cancer in the IPATential 150 trial.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 24, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news

Pembrolizumab Shows Activity in Select Rare Sarcomas Pembrolizumab Shows Activity in Select Rare Sarcomas
The checkpoint inhibitor prolonged progression-free survival in patients with four subtypes of metastatic or unresectable locally advanced sarcomas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lorlatinib: Another First-Line Option for ALK-Positive NSCLC? Lorlatinib: Another First-Line Option for ALK-Positive NSCLC?
First-line lorlatinib significantly prolonged progression-free survival compared with crizotinib in advanced ALK-positive nonsmall cell lung cancer, according to a phase 3 interim analysis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 24, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCI May'Kill' Major Mammography Trial, Says Advisor NCI May'Kill' Major Mammography Trial, Says Advisor
An advisory group to the National Cancer Institute is reviewing the"feasibility and relevance" of the ongoing TMIST trial that is comparing 3-D to 2-D mammography and is asking if it should continue.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCI to ‘'Kill' Major Mammography Trial, Says Advisor NCI to ‘'Kill' Major Mammography Trial, Says Advisor
An advisory group to the National Cancer Institute is reviewing the"feasibility and relevance" of the ongoing TMIST trial that is comparing 3-D to 2-D mammography and is asking if it should continue.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Paradigm Shift' in Gastric Junction Cancers With Nivolumab'Paradigm Shift' in Gastric Junction Cancers With Nivolumab
Nivolumab immunotherapy could soon be used in the first-line in gastric or gastroesophageal junction cancers, improving the traditionally poor outcomes seen with chemotherapy, show latest trials.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 23, 2020 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Cancer Treatment May Make COVID-19 Less, Not More, Severe Cancer Treatment May Make COVID-19 Less, Not More, Severe
Cancer treatment appears to alter a patient's immune response to COVID-19 to make infection less severe, and not more severe as has been assumed, suggests a small Israeli study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A Glimmer of Hope for Immunotherapy in SCLC? A Glimmer of Hope for Immunotherapy in SCLC?
While combination immunotherapy did not show a survival benefit after chemoradiotherapy in small cell lung cancer, longer follow-up and biomarker analysis may reveal some gains, suggests trial data.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Impact of Overweight and Obesity on Thyroid Cancer Incidence Impact of Overweight and Obesity on Thyroid Cancer Incidence
The incidence of papillary thyroid cancer is on the rise in recent years, as is the prevalence of obesity. Is there a connection?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 23, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

New First-Line Standard of Care for Esophageal Cancer? New First-Line Standard of Care for Esophageal Cancer?
Pembrolizumab plus chemotherapy should be a new standard of care for first-line treatment, say researchers. Patients with squamous cell carcinomas and higher levels of PD-L1 benefited most.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Liquid Biopsy Might Help Detect, Manage Liver Cancer in the Future Liquid Biopsy Might Help Detect, Manage Liver Cancer in the Future
Liquid biopsy could someday be useful for the early detection and clinical management of hepatocellular carcinoma (HCC), according to a new review.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 23, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Not All Prostate Cancer Mutations Created Equal for Olaparib Not All Prostate Cancer Mutations Created Equal for Olaparib
While the PARP inhibitor olaparib is the first of its kind to show an overall survival benefit in progressed metastatic prostate cancer, questions remain over its use in men without BRCA1/2 mutations.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How I Diagnose Low-Grade Myelodysplastic Syndromes How I Diagnose Low-Grade Myelodysplastic Syndromes
Using case studies, the authors discuss their approach to the diagnosis of low-grade myelodysplastic syndromes, a group of myeloid neoplasms that are often challenging to diagnose.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Beyond Misuse: AEs and Opioids in Older Cancer Survivors Beyond Misuse: AEs and Opioids in Older Cancer Survivors
These findings underscore concerns about the use of opioids in this population as they demonstrate a significantly increased risk of'multiple preventable serious adverse drug events. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

A Breath Test to Diagnose Head and Neck Cancer A Breath Test to Diagnose Head and Neck Cancer
Breath analysis for non-invasive diagnosis of early-stage head and neck squamous cell carcinoma appears to be practical and accurate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Survey Quantifies COVID-19's Impact on Oncology Survey Quantifies COVID-19's Impact on Oncology
The survey showed that'COVID-19 has had a major impact on the organization of patient care, on the well-being of caregivers … and on clinical trial activities in oncology,'said a presenter at ESMO 2020.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Aspirin Tied to Higher Risk of Advanced Cancer Diagnosis, Mortality Aspirin Tied to Higher Risk of Advanced Cancer Diagnosis, Mortality
Older adults who take daily low-dose aspirin may be more likely than those who don't to be diagnosed with advanced cancers and to die from them, a randomized trial suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 22, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Geriatric Comanagement Tied to Lower Mortality After Cancer Surgery Geriatric Comanagement Tied to Lower Mortality After Cancer Surgery
Patients aged 75 and older who undergo cancer surgery have lower 90-day postoperative mortality when they receive geriatric co-management than when they don't, a recent study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 22, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Radiosurgery Appears to Benefit Old & Young With Brain Metastases Radiosurgery Appears to Benefit Old & Young With Brain Metastases
Stereotactic radiosurgery provides similar overall survival in patients older and younger than 75 years who have brain metastases from lung cancer, according to a retrospective study from Japan.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 22, 2020 Category: Radiology Tags: Hematology-Oncology News Source Type: news

HPV-Mediated Head, Neck Cancers Predicted to Rise for Decades HPV-Mediated Head, Neck Cancers Predicted to Rise for Decades
Expect another 30 to 40 years of increasing numbers of HPV-related oropharynx cancers, said an expert.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Abemaciclib Cuts Early Recurrence in High-risk Breast Cancer Abemaciclib Cuts Early Recurrence in High-risk Breast Cancer
Patients with HR+, HER2- breast cancer at high risk of early recurrence on endothelial therapy could highly improve their invasive disease-free survival with adjuvant abemaciclib, a new trial shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Assessing Biomarkers in Metastatic Breast Cancer Assessing Biomarkers in Metastatic Breast Cancer
Determining treatment options, as well as the prognosis of patients, may rely on changes in biomarker status during the course of advanced disease progression.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

Lenvatinib Combo May Offer Hope After Immunotherapy in Melanoma Lenvatinib Combo May Offer Hope After Immunotherapy in Melanoma
The combination of lenvatinib and pembrolizumab may extend by more than 1 year the lives of patients with advanced melanoma who progress after immunotherapy, show'important'trial results.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Sotorasib Is a'Triumph of Drug Discovery' in Cancer Sotorasib Is a'Triumph of Drug Discovery' in Cancer
The drug inhibits KRAS p.G12C-mutant tumors, which are seen in about 13% of patients with non-small cell lung cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Nivo-Cabo Combo Joins Advanced RCC Treatment Ranks Nivo-Cabo Combo Joins Advanced RCC Treatment Ranks
The PD-1 inhibitor/TKI combination is the latest to show superior survival in comparison with sunitinib as first-line therapy for patients with metastatic renal cell carcinoma (RCC).Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 21, 2020 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news

First-in-Class ADC Ups Survival in mTNBC First-in-Class ADC Ups Survival in mTNBC
For patients with metastatic triple-negative breast cancer for whom several therapies failed, progression-free and overall survival almost doubled with the novel antibody-drug conjugate, trial data indicate.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 21, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

How Cancer Shaped Justice Ruth Bader Ginsburg ’s Life and Work
The name Ruth Bader Ginsburg became almost synonymous with strength and stamina as she rose to prominence in judicial and feminist circles throughout her long career. Famously nicknamed the Notorious RBG and known for her grueling fitness regimen, the late Supreme Court justice also struggled with cancer and other health issues for the better part of her time on the bench — culminating with her death on Sept. 18 at the age of 87 of complications from metastatic pancreatic cancer. Ginsburg’s health issues became public in 1999, six years after her appointment to the Supreme Court, when she had surgery for early-...
Source: TIME: Health - September 19, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime remembrance Source Type: news

Medicare Will Test Pay Models for Radiation Oncology, Dialysis Medicare Will Test Pay Models for Radiation Oncology, Dialysis
CMS unveiled a final rule allowing Medicare to next year begin a test of bundled payment for radiation therapy. The rule also approves a kidney care model that encourages use of home-based treatments.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Threefold Higher Risk for Breast Cancer Death With DCIS Threefold Higher Risk for Breast Cancer Death With DCIS
Compared to the general population, women with ductal carcinoma in situ (DCIS) were more than three times more likely to die from breast cancer; the risk was particularly high for Black women and young women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Almost 90,000 Young American Adults Will Get Cancer This Year: Report
FRIDAY, Sept. 18, 2020 -- Nearly 90,000 Americans between 15 and 39 years of age will be diagnosed with cancer this year and more than 9,200 will die, a new report projects. One hematologist who deals with younger cancer patients said the shock of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 18, 2020 Category: General Medicine Source Type: news